Investment Summary |
|
|---|---|
| Date | 2013-12-31 |
| Target | SK Incheon Petrochem |
| Sector | Chemicals |
| Investor(s) | Stonebridge Capital |
| Deal Type | Growth Capital |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 2008 |
| PE ASSETS | 118M KRW |
| Size | Small |
| Type | Sector Agnostic |
Stonebridge Capital is a Korean private equity and venture capital firm focused on investing in growth businesses at all company stages. Stonebridge looks for businesses that have the potential to be market leaders. Sectors of interest include consumer goods, value-added manufacturing, media/entertainment, healthcare, financial services, business services, real estate, and oil/gas exploration. The Firm generally targets businesses operating in Korea, China, and Japan. Stonebridge Capital was formed in 2008 and is based in Seoul.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 8 |
| Sector (Chemicals) | 1 of 1 |
| Type (Growth Capital) | 7 of 7 |
| Country (South Korea) | 7 of 7 |
| Year (2013) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-01-01 |
Corentec
Cheonan, South Korea Corentec is a medical device technology company that manufacturers artificial joints. Corentec was founded in 2000 and is based in Cheonan, South Korea. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-01-01 |
Green Cross Biotherapeutics
Montreal, Quebec, Canada Green Cross Biotherapeutics, Inc. specializes in the development and manufacture of plasma derivatives, preventive vaccines, recombinant proteins and therapeutic antibodies. |
Buy | - |
